4D Molecular Therapeutics Inc at Chardan Genetic Medicines Conference Transcript
It is now my pleasure to introduce our next guests, Uneek Mehra, Chief Financial and Business Officer; and Julian Pei, Head of IR and Corporate Finance at 4D Molecular Therapeutics. The format for this session is a fireside chat, which we might open to audience Q&A at the end if there's time. And Uneek will also be participating in our next-gen AAV panel at 3:00.
Thank you for joining us today.
Questions & Answers
To begin with, can you give us a high-level overview of 4D Molecular and its AAV platform, and also talk about key catalysts for the year? Either of you can jump in on this.
Yeah, sure. Good afternoon and thank you for having us. It's an exciting conference. So 4D Molecular Therapeutics. It's an exciting stage in time for the platform. Our mission is to continue to unlock the full potential
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |